Literature DB >> 4385122

Studies of intestinal microflora. V. Fecal microbial ecology in ulcerative colitis and regional enteritis: relationship to severity of disease and chemotherapy.

S L Gorbach, L Nahas, A G Plaut, L Weinstein, J F Patterson, R Levitan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4385122

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  34 in total

1.  Frontiers in inflammatory bowel disease. The proceedings of a conference sponsored by the McReynolds Foundation. Part 1.

Authors: 
Journal:  Am J Dig Dis       Date:  1975-06

2.  Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease.

Authors:  M H Giaffer; C D Holdsworth; B I Duerden
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

3.  Microbial fingerprinting detects unique bacterial communities in the faecal microbiota of rats with experimentally-induced colitis.

Authors:  Ashis K Samanta; Valeria A Torok; Nigel J Percy; Suzanne M Abimosleh; Gordon S Howarth
Journal:  J Microbiol       Date:  2012-04-27       Impact factor: 3.422

Review 4.  Evidence for the involvement of infectious agents in the pathogenesis of Crohn's disease.

Authors:  Gert De Hertogh; Jeroen Aerssens; Karen P Geboes; Karel Geboes
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

Review 5.  Phagocytes, toxic oxygen metabolites and inflammatory bowel disease: implications for treatment.

Authors:  J G Williams
Journal:  Ann R Coll Surg Engl       Date:  1990-07       Impact factor: 1.891

Review 6.  Escherichia coli and ulcerative colitis.

Authors:  D Burke
Journal:  J R Soc Med       Date:  1997-11       Impact factor: 5.344

7.  Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease.

Authors:  C Favier; C Neut; C Mizon; A Cortot; J F Colombel; J Mizon
Journal:  Dig Dis Sci       Date:  1997-04       Impact factor: 3.199

8.  Lancemaside A ameliorates colitis by inhibiting NF-kappaB activation in TNBS-induced colitis mice.

Authors:  Eun-Ha Joh; In-Ah Lee; Sang-Jun Han; Sunju Chae; Dong-Hyun Kim
Journal:  Int J Colorectal Dis       Date:  2009-12-03       Impact factor: 2.571

9.  The humoral immune system in inflammatory bowel disease. II. Immunologlobulin levels.

Authors:  H J Hodgson; D P Jewell
Journal:  Am J Dig Dis       Date:  1978-02

10.  Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-kappaB activation in experimental colitis.

Authors:  Jung-Hee Lee; Bomi Lee; Hye-Sung Lee; Eun-Ah Bae; Hoyong Lee; Young-Tae Ahn; Kwang-Sei Lim; Chul-Sung Huh; Dong-Hyun Kim
Journal:  Int J Colorectal Dis       Date:  2008-12-03       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.